TCR2 THERAPEUTICS INC. Quarterly Common Stock, Shares Authorized from Q4 2018 to Q1 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Tcr2 Therapeutics Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2018 to Q1 2023.
  • Tcr2 Therapeutics Inc. Common Stock, Shares Authorized for the quarter ending March 31, 2023 was 150M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 150M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 150M 0 0% Dec 31, 2022 10-Q 2023-05-11
Q3 2022 150M 0 0% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 150M 0 0% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 150M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 150M 0 0% Dec 31, 2021 10-K 2023-03-23
Q3 2021 150M 0 0% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 150M 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 150M 0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 150M 0 0% Dec 31, 2020 10-K 2022-03-22
Q3 2020 150M 0 0% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 150M 0 0% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 150M 0 0% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 150M +129M +615% Dec 31, 2019 10-K 2021-03-16
Q3 2019 150M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 150M Jun 30, 2019 10-Q 2019-08-09
Q1 2019 150M Mar 31, 2019 10-Q 2019-05-13
Q4 2018 21M Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.